How Targeted Cancer Drugs Disrupt the Cell Cycle
PLOS: DNA Science
JUNE 22, 2023
I recalled Heather’s early mastery of mitosis last week when the news reported promising clinical trial results for a cancer drug for brain tumors that targets a protein, called survivin , that controls the cell cycle. The candidate drug, vorasidenib, is a small molecule that inhibits survivin. ” she answered.
52 
Let's personalize your content